Content-Transfer-Encoding: |
7bit |
Sender: |
|
Subject: |
|
From: |
|
Date: |
Fri, 5 Jan 2001 12:59:48 +0200 |
Content-Type: |
text/plain; charset="windows-1255" |
MIME-Version: |
1.0 |
Reply-To: |
|
Parts/Attachments: |
|
|
Pat, you are so right, and when I first saw that they were using dostinex, I
asked one of the docs to show me references on the safety and efficacy of
this med. Here are two that I have on file, which they gave me. A bit
outdated wuoldn't you say? (Cabergoline is Dostinex)
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui
ds=8713691&dopt=Abstract
Drug Saf 1996 Apr;14(4):228-38
A comparative review of the tolerability profiles of dopamine agonists in
the treatment of hyperprolactinaemia and inhibition of lactation.
Webster J
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui
ds=1676318&dopt=Abstract
: BMJ 1991 Jun 8;302(6789):1367-71
Single dose cabergoline versus bromocriptine in inhibition of puerperal
lactation: randomised, double blind, multicentre study. European Multicentre
Study Group for Cabergoline in Lactation Inhibition.
Apparently it is used in Europe. Even Hale has a reference to it saying
that it is safer than parlodel.
I would love an argument to prove that it is not accepted in the US, if you
have any references
In the meantime, I keep knocking it off the table into the trash.....clumsy
me!!!!!
I have to give a lecture to the gynies in our hospital in the end of March,
and would love to throw this in just for fun!!
Esther G
Tel Aviv
***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html
|
|
|